Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S More

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Postgraduate Medical Journal|January 22, 2000
Antiplatelet use in interventional cardiologyA Brodison, R Katira, R S More, et al.
European Heart Journal|November 1, 1993
Heparin after angioplasty: an unresolved issue?R S More, M J Brack, A H Gershlick
Platelets|November 4, 2010
Targeted antiplatelet therapyR S More, M J Underwood, A H Gershlick
Thrombosis and Haemostasis|January 1, 1994
Targeting fibrinolytic agents to the vessel wall: a new therapeutic niche?R S More, M J Underwood, D P De Bono
Thrombosis Research|May 15, 1993
Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitroM J Brack, R S More, E Spring, et al.
Coronary Artery Disease|June 1, 1994
Absence of a prothrombotic state in restenotic patients?M J Brack, R S More, S Pringle, et al.
International Journal of Cardiology|January 1, 1993
Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparinM J Brack, R S More, P J Hubner, et al.
Journal of Vascular Research|July 1, 1993
Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganeseM J Underwood, R S More, M M Thompson, et al.
The American Journal of Cardiology|May 15, 1994
Growth factor persistence after vessel wall injury in a rabbit angioplasty modelR S More, M J Brack, M J Underwood, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993
The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin timesM J Brack, R S More, P J Hubner, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Postgraduate Medical Journal|January 22, 2000
Antiplatelet use in interventional cardiologyA Brodison, R Katira, R S More, et al.
European Heart Journal|November 1, 1993
Heparin after angioplasty: an unresolved issue?R S More, M J Brack, A H Gershlick
Platelets|November 4, 2010
Targeted antiplatelet therapyR S More, M J Underwood, A H Gershlick
Thrombosis and Haemostasis|January 1, 1994
Targeting fibrinolytic agents to the vessel wall: a new therapeutic niche?R S More, M J Underwood, D P De Bono
Thrombosis Research|May 15, 1993
Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitroM J Brack, R S More, E Spring, et al.
Coronary Artery Disease|June 1, 1994
Absence of a prothrombotic state in restenotic patients?M J Brack, R S More, S Pringle, et al.
International Journal of Cardiology|January 1, 1993
Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparinM J Brack, R S More, P J Hubner, et al.
Journal of Vascular Research|July 1, 1993
Reduction of vein graft intimal hyperplasia by ex vivo treatment with desferrioxamine manganeseM J Underwood, R S More, M M Thompson, et al.
The American Journal of Cardiology|May 15, 1994
Growth factor persistence after vessel wall injury in a rabbit angioplasty modelR S More, M J Brack, M J Underwood, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993
The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin timesM J Brack, R S More, P J Hubner, et al.
Pageof 5